Delivery Order SPE2DB20D2104-SPE2DB25FMVNN
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,167.64 firm fixed-price contract is for the delivery of Everolimus 5 mg tablets. The contract has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Everolimus 10 mg tablets, a medication used to treat certain medical conditions. The contract has a ceiling value of $3,291.25 and a completion date of June 18, 2025. The contract is a firm fixed-price type and is not a set-aside contract, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,244.68 firm fixed-price delivery order is for the supply of Everolimus 5 mg tablets in 28-count units. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Everolimus 0.5 mg tablets, a medication used for various medical conditions. The contract has a firm fixed price of $15,880.66 and a completion date of September 12, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Everolimus 10 mg tablets. The contract, valued at $1,360.76, runs through September 14, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Everolimus 5 mg tablets, a medication used for various medical treatments. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $9,311.67 and a performance period ending on May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of EVEROLIMUS 10 MG TABLET 30S. The contract has a firm fixed price of $52,960.28 and a performance period through July 14, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a $17,500.49 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4560437634 - EVEROLIMUS 10 MG TABLET 30S. The contract has an ultimate completion date of March 31, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.25 mg everolimus tablets, a medication used to treat certain medical conditions. The contract has a ceiling value of $20,122.10 and a performance period ending on May 23, 2025. This is a firm fixed-price contract with no set-aside designation, indicating open competition....
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $4,500.00. The contract is for the delivery of Everolimus 0.75 mg tablets, a pharmaceutical product used for various medical treatments. The award does not indicate any set-aside requirements, suggesting open competition. As a key DLA vendor, Amerisourcebergen provides...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVNNDelivery Order
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $5,153.99 fixed-price contract is for the delivery of Everolimus 0.75 mg tablets, a medication, with a period of performance through July 16, 2025. The contract is not set aside and is funded by the Defense agency. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 7/15/25 |